Renovaro Biosciences (RENB) Q1 2023 Earnings

12MayExpected
Q4 2021
Q1 2022
Q4 2022
Q1 2023
-1.7
-1.13
-0.57
0

Details

Expected EPS
N/A
Actual EPS
-0.08
Surprise EPS
-0.08
Surprise Percent
+∞%

Description

Renovaro Biosciences (RENB) has reported earnings of -0.08 per share for Q1 2023.

0 Comments

Share your thoughts